Abstract
Diabetes mellitus type 1 and 2 affects people worldwide and is associated with further complications like macrovascular, microvascular and its effect is observed as retinopathy, cardiovascular diseases, nephropathy and many more diseases. There are numerous suggestions, treatments for presentation and controlling diabetes but no curative agents. Therefore the aim is to prevent or delay onset or control the complications. This work outlines the principle strategies for management of type 2 diabetes.
Keywords: Aspirin, Diet Control, hypertension, LDL cholesterol, ACE Inhibitors
Current Diabetes Reviews
Title: Therapeutic Management Strategies for Type 2 Diabetes
Volume: 2 Issue: 3
Author(s): C. Ramesh, V. Gopal, K. Sembulingam and M. Nappinnai
Affiliation:
Keywords: Aspirin, Diet Control, hypertension, LDL cholesterol, ACE Inhibitors
Abstract: Diabetes mellitus type 1 and 2 affects people worldwide and is associated with further complications like macrovascular, microvascular and its effect is observed as retinopathy, cardiovascular diseases, nephropathy and many more diseases. There are numerous suggestions, treatments for presentation and controlling diabetes but no curative agents. Therefore the aim is to prevent or delay onset or control the complications. This work outlines the principle strategies for management of type 2 diabetes.
Export Options
About this article
Cite this article as:
Ramesh C., Gopal V., Sembulingam K. and Nappinnai M., Therapeutic Management Strategies for Type 2 Diabetes, Current Diabetes Reviews 2006; 2 (3) . https://dx.doi.org/10.2174/157339906777950633
DOI https://dx.doi.org/10.2174/157339906777950633 |
Print ISSN 1573-3998 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6417 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Nanocarriers Assisted siRNA Gene Therapy for the Management of Cardiovascular Disorders
Current Pharmaceutical Design Glucose Metabolism and Antidepressant Medication
Current Pharmaceutical Design General Aspects of Metal Toxicity
Current Medicinal Chemistry Psychotropics and Fertility
Current Women`s Health Reviews Recent Advances in Obesity Pharmacotherapy
Current Clinical Pharmacology The Use of Carvedilol in Pediatric Heart Failure
Cardiovascular & Hematological Disorders-Drug Targets New Horizons in Diabetes Therapy
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Sympathetic Overactivity in Patients with Chronic Renal Failure - The Culprit of Increased Cardiovascular Mortality?
Current Hypertension Reviews Microalbuminuria In Primary Hypertension
Current Hypertension Reviews Obesity and Insulin Resistance: A Review of Molecular Interactions
Current Molecular Medicine Benefits of SGLT2 Inhibitors Beyond Glycemic Control – A Focus on Metabolic, Cardiovascular and Renal Outcomes
Current Diabetes Reviews Adipose Tissue Macrophages, Low Grade Inflammation and Insulin Resistance in Human Obesity
Current Pharmaceutical Design Adverse Effects of Statins - Mechanisms and Consequences
Current Drug Safety Antivirals Used for Influenza Chemoprophylaxis
Current Medicinal Chemistry HIV-1 Vectors: Fulfillment of Expectations, Further Advancements, and Still A Way To Go
Current HIV Research Pharmacology and Chemistry of Diabetes mellitus and Antidiabetic Drugs: A Critical Review
Current Medicinal Chemistry Epigenetic Modifications of the Nuclear Factor Kappa B Signalling Pathway and its Impact on Inflammatory Bowel Disease
Current Pharmaceutical Design Opportunistic Pathogens in Diabetic Foot Lesions
Current Diabetes Reviews Use of BNP and CRP as Biomarkers in Assessing Cardiovascular Disease:Diagnosis Versus Risk
Current Vascular Pharmacology Intravitreal Bevacizumab (Avastin®) for Diabetic Retinopathy at 24-months: The 2008 Juan Verdaguer-Planas Lecture
Current Diabetes Reviews